Quest PharmaTech Inc.
QPTFF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $329 | $543 | $336 | $170 |
| G&A Expenses | $488 | $773 | $483 | $612 |
| SG&A Expenses | $488 | $819 | $536 | $639 |
| Sales & Mktg Exp. | $0 | $46 | $53 | $26 |
| Other Operating Expenses | $0 | -$46 | -$38 | $0 |
| Operating Expenses | $817 | $1,316 | $834 | $809 |
| Operating Income | -$817 | -$1,316 | -$834 | -$809 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$984 | -$1,702 | -$64,054 | -$84,229 |
| Pre-Tax Income | -$1,801 | -$3,018 | -$64,888 | -$85,039 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1,801 | -$3,018 | -$64,888 | -$85,039 |
| % Margin | – | – | – | – |
| EPS | -0.011 | -0.018 | -0.39 | -0.51 |
| % Growth | 40.4% | 95.4% | 23.5% | – |
| EPS Diluted | -0.011 | -0.018 | -0.39 | -0.51 |
| Weighted Avg Shares Out | 163,732 | 169,132 | 168,395 | 168,239 |
| Weighted Avg Shares Out Dil | 169,129 | 169,129 | 168,395 | 168,239 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $23 | $21 | $21 | $13 |
| Depreciation & Amortization | $3 | $3 | $13 | $2 |
| EBITDA | -$814 | -$1,313 | -$821 | -$789 |
| % Margin | – | – | – | – |